The anti-infective drug market is seeing strong growth due to multiple interrelated factors. One key driver is the rising incidence of specific infectious diseases, including healthcare-associated infections, sexually transmitted diseases (STDs), and respiratory infections. These […]
The ALK inhibitors market is projected to expand in the near future. This growth is driven by the rising number of cancer diagnoses, heightened awareness of ALK inhibitors, and the increasing number of these inhibitors […]
Novavax expects pre-filled syringes will be broadly available in thousands of locations across the U.S. Novavax’s vaccine is the only protein-based option available in the U.S. for use in individuals aged 12 and older to […]
para el tratamiento de pacientes adultos con cáncer de pulmón de células no pequeñas (CPCNP) avanzado con una mutación BRAFV600E La aprobación europea se basa en los resultados del ensayo de fase II PHAROS, que mostró […]
BEIJING and SHANGHAI and BOSTON, Aug. 30, 2024 /PRNewswire/ — Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, today announced that it has granted the China rights (including mainland China, Hong Kong, Macau, […]